Table 2 |
|
|
List of some important drugs under clinical trials for weight reduction. |
|
|
Drugs in phase II trials |
Drugs in phase III trials |
|
|
|
|
Bupropion (dopamine reuptake inhibitor) |
Mazindol (adrenergic agonist) |
|
Linitript (cholecystokinin A antagonist) |
Sertraline (selective serotonin uptake inhibitor) |
|
Pegylated leptin |
Posatirelin (thyrotrphin-releasing hormone analogue) |
|
Dipeptidyl peptidase IV inhibitors |
Cannabinoid antagonists |
|
Human growth hormone factor AOD9604 |
Lipase inhibitor, ATL-962 |
|
Phytostanol |
|
|
|
|
|
Nammi et al. Nutrition Journal 2004 3:3 doi:10.1186/1475-2891-3-3 |
|